Literature DB >> 10545017

Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells.

E T Walch1, D Marchetti.   

Abstract

The role of the neurotrophins (NTs) and their corresponding receptors (NTRs) TrkA, TrkB, TrkC, and p75NTR in neoplasia has received relatively little attention. However, because malignant cell migration within the prostate occurs predominantly by direct extension around prostatic nerves, the presence and possible upregulation of NTs from autocrine/paracrine sources and NTR expression within prostate epithelial tumor cells may be important in metastasis. We have been addressing their expression and interactions in human prostate cancer cell lines (LNCaP, PC-3, and DU145) and their role in prostate cancer invasion. In this study, we demonstrated that nerve growth factor (NGF), the prototypic NT, and NT-4/5 increased in vitro invasion through a reconstituted basement membrane and induced time- and dose-dependent expression of heparanase, a heparan sulfate-specific endo-beta-D-glucuronidase, an important molecular determinant of tumor metastasis. The NT effects were most marked in the DU 145 brain-metastatic cells and were detected at NT concentrations sufficient to fully saturate both low- and high-affinity NTRs. Additionally, we characterized the molecular expression of NT high-affinity (Trk) and low-affinity (p75NTR) receptors in these cell lines by reverse transcription-polymerase chain reaction. These lines had negligible trkA and trkC expression, although trkB was expressed in the three prostatic tumor cell lines examined. The brain-metastatic DU 145 cells were also positive for p75NTR. Our data showed that the NTs and NTRs are important in metastasis and that their expression coincides with transformation to a malignant phenotype capable of invasion along the perineural space and extracapsular metastasis to distant sites. These findings set the stage for more research into this area as related to prostate cancer evolution and may improve therapy for prostate cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545017     DOI: 10.1023/a:1006652605568

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  54 in total

1.  Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.

Authors:  D Marchetti
Journal:  J Cell Physiol       Date:  1997-09       Impact factor: 6.384

Review 2.  Biological sources of nerve growth factor.

Authors:  R A Murphy; A Y Watson; J A Rhodes
Journal:  Appl Neurophysiol       Date:  1984

3.  Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate.

Authors:  R Dalal; D Djakiew
Journal:  Mol Cell Endocrinol       Date:  1997-10-31       Impact factor: 4.102

4.  Genomic organization of the human NTRK1 gene.

Authors:  A Greco; R Villa; M A Pierotti
Journal:  Oncogene       Date:  1996-12-05       Impact factor: 9.867

5.  Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors.

Authors:  G L Nicolson; M Nakajima; J L Herrmann; D G Menter; P G Cavanaugh; J S Park; D Marchetti
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines.

Authors:  D MacGrogan; J P Saint-André; E Dicou
Journal:  J Neurochem       Date:  1992-10       Impact factor: 5.372

7.  Neurotrophin gene expression by cell lines derived from human gliomas.

Authors:  W Hamel; M Westphal; E Szönyi; E Escandón; K Nikolics
Journal:  J Neurosci Res       Date:  1993-02-01       Impact factor: 4.164

8.  Expression of a Trk high affinity nerve growth factor receptor in the human prostate.

Authors:  B R Pflug; C Dionne; D R Kaplan; J Lynch; D Djakiew
Journal:  Endocrinology       Date:  1995-01       Impact factor: 4.736

9.  Genomic characterization of the human trkC gene.

Authors:  N Ichaso; R E Rodriguez; D Martin-Zanca; R Gonzalez-Sarmiento
Journal:  Oncogene       Date:  1998-10-08       Impact factor: 9.867

10.  Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen.

Authors:  S M Chang; L W Chung
Journal:  Endocrinology       Date:  1989-11       Impact factor: 4.736

View more
  11 in total

1.  TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.

Authors:  Jamie L Croucher; Radhika Iyer; Nanxin Li; Valentina Molteni; Jon Loren; W Perry Gordon; Tove Tuntland; Bo Liu; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2014-11-14       Impact factor: 3.333

2.  AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.

Authors:  Radhika Iyer; Carly R Varela; Jane E Minturn; Ruth Ho; Anisha M Simpson; Jennifer E Light; Audrey E Evans; Huaqing Zhao; Kenneth Thress; Jeffrey L Brown; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2012-05-24       Impact factor: 3.333

3.  Expression of heparanase mRNA in anti-sense oligonucleotide-transfected human esophageal cancer EC9706 cells.

Authors:  Kui-Sheng Chen; Lan Zhang; Lin Tang; Yun-Han Zhang; Dong-Ling Gao; Liang Yan; Lei Zhang
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

Review 4.  Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.

Authors:  Mary C Farach-Carson; Curtis R Warren; Daniel A Harrington; Daniel D Carson
Journal:  Matrix Biol       Date:  2013-08-31       Impact factor: 11.583

5.  The p75 neurotrophin receptor appears in plasma in diabetic rats-characterisation of a potential early test for neuropathy.

Authors:  L Chilton; A Middlemas; N Gardiner; D R Tomlinson
Journal:  Diabetologia       Date:  2004-11-19       Impact factor: 10.122

6.  TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells.

Authors:  Siyang Zhang; Dawei Guo; Wenting Luo; Qingfu Zhang; Ying Zhang; Chunyan Li; Yao Lu; Zeshi Cui; Xueshan Qiu
Journal:  BMC Cancer       Date:  2010-02-16       Impact factor: 4.430

7.  TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.

Authors:  Ramesh Singh; Dileep Karri; Hong Shen; Jiangyong Shao; Subhamoy Dasgupta; Shixia Huang; Dean P Edwards; Michael M Ittmann; Bert W O'Malley; Ping Yi
Journal:  J Clin Invest       Date:  2018-06-18       Impact factor: 14.808

8.  Significance of nerve growth factor overexpression and its autocrine loop in oesophageal squamous cell carcinoma.

Authors:  S Tsunoda; T Okumura; T Ito; Y Mori; T Soma; G Watanabe; J Kaganoi; A Itami; Y Sakai; Y Shimada
Journal:  Br J Cancer       Date:  2006-07-11       Impact factor: 7.640

Review 9.  Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.

Authors:  Rocío Retamales-Ortega; Lorena Oróstica; Carolina Vera; Paula Cuevas; Andrea Hernández; Iván Hurtado; Margarita Vega; Carmen Romero
Journal:  Int J Mol Sci       Date:  2017-02-26       Impact factor: 5.923

10.  Nerve growth factor in cancer cell death and survival.

Authors:  Niamh H Molloy; Danielle E Read; Adrienne M Gorman
Journal:  Cancers (Basel)       Date:  2011-02-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.